Contraceptive Devices Market Analysis, Trends, Growth, Research And Forecast 2033

The Business Research Company recently released a comprehensive report on the Global Contraceptive Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18320&type=smp

According to The Business Research Company's, The contraceptive devices market size has grown strongly in recent years. It will grow from $12.05 billion in 2023 to $12.8 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to growing awareness about the importance of family planning and contraceptive methods, government initiatives, increasing global population, greater focus on women's health and empowerment, improving access to healthcare facilities.

The contraceptive devices market size is expected to see strong growth in the next few years. It will grow to $16.43 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing awareness of sexual health and STD prevention, economic benefits of controlling family size, growing cultural acceptance of contraceptive use, high proportion of young population in reproductive age, influence of social media on spreading awareness. Major trends in the forecast period include innovations in contraceptive technologies, educational campaigns by NGOs and health organizations advancements in pharmaceutical formulations, availability of a wide range of contraceptive products, investment in research and development for new contraceptive methods.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Market Drivers and Trends:

The growing prevalence of sexually transmitted diseases is expected to propel the growth of the contraceptive device market going forward. Sexually transmitted diseases (STDs) are infections transmitted primarily through sexual contact, affecting various body parts and potentially leading to a range of symptoms and health complications. Sexually transmitted diseases are rising due to increased sexual activity, a lack of proper protection, insufficient sexual health education, and challenges in access to healthcare and testing. Contraceptive devices, especially condoms, are required for sexually transmitted diseases because they provide a barrier that reduces the risk of transmission by preventing direct contact with infectious fluids and lesions. For instance, in July 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, in England, there were 401,800 new STI diagnoses in 2023, marking a 4.7% increase from the 383,789 cases reported in 2022. Diagnoses of gonorrhoea rose by 7.5%, from 79,268 in 2022 to 85,223 in 2023. Meanwhile, infectious syphilis diagnoses saw a 9.4% increase, rising from 8,693 in 2022 to 9,513 in 2023. Therefore, the growing prevalence of sexually transmitted diseases is driving the growth of the contraceptive device market.

Major companies operating in the contraceptive device market are developing innovative products, such as contraceptive vaginal rings, to provide a convenient, low-maintenance method of birth control with a once-a-month insertion. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina that prevents pregnancy by continuously releasing hormones to inhibit ovulation and thicken cervical mucus. For instance, in October 2023, Xiromed LLC, a US-based pharmaceuticals company, launched the EnilloRing. The EnilloRing, developed by Xiromed, is a contraceptive vaginal ring that combines etonogestrel and ethinyl estradiol. It is designed for long-term use, remaining in place for three weeks. After this period, it is followed by a one-week ring-free interval to effectively prevent pregnancy.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Boehringer Ingelheim International GmbH., Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Zondervan, Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Medisafe Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited

Contraceptive Devices Market 2024 Key Insights:

• The contraceptive devices market size is expected to see strong growth in the next few years. It will grow to $16.43 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.
• Rising Prevalence Of STDs Propels The Contraceptive Devices Market
• Innovative Products In The Contraceptive Device Market
• North America was the largest region in the contraceptive devices market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=18320&type=smp

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.